Amicus Therapeutics Gains 3% On Favorable EU Medicines Recommendation By: Benzinga via Benzinga April 01, 2016 at 14:37 PM EDT Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD), a bio-pharmaceutical company that focuses on the treatment of rare and orphan ... Read More >> Related Stocks: Amicus Therapeutics